Insider · CIK 0001572451

Bonita David P

CIK 0001572451 Name as filed on the most recent filing

Filed as Bonita David P (34)

86 transaction lines · from 34 filings · filed 2013-05-22 to 2026-04-23 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

86 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-04-21 P, Open-market purchase Prelude Therapeutics IncPRLD 2 lines 12,499,999, acquired Open Form 4 filing 0000947871-26-000462
2025-07-25 P, Open-market purchase ImageneBio, Inc.IMA 2,499,969, acquired Open Form 4 filing 0001415889-25-020601
2023-05-22 P, Open-market purchase Prelude Therapeutics IncPRLD 4,999,999, acquired Open Form 4 filing 0000947871-23-000627
2022-11-25 S, Open-market sale Tricida, Inc.TCDA 798,430, disposed Open Form 4 filing 0000947871-22-001207
2022-11-23 S, Open-market sale Tricida, Inc.TCDA 1,179,633, disposed Open Form 4 filing 0000947871-22-001207
2022-11-22 S, Open-market sale Tricida, Inc.TCDA 227,573, disposed Open Form 4 filing 0000947871-22-001207
2022-09-19 P, Open-market purchase Third Harmonic Bio, Inc.THRD 5,100,000, acquired Open Form 4 filing 0001209191-22-050937
2022-06-24 P, Open-market purchase Ikena Oncology, Inc.IKNA 2 lines 803,975, disposed Open Form 4 filing 0000947871-22-000721
2022-06-23 P, Open-market purchase Ikena Oncology, Inc.IKNA 86,884, disposed Open Form 4 filing 0000947871-22-000721
2022-06-22 P, Open-market purchase Ikena Oncology, Inc.IKNA 237,161, disposed Open Form 4 filing 0000947871-22-000721
2021-09-07 S, Open-market sale Repare Therapeutics Inc.RPTX 2 lines 30,096, disposed Open Form 4 filing 0000947871-21-000987
2021-09-03 S, Open-market sale Repare Therapeutics Inc.RPTX 2 lines 244,698, disposed Open Form 4 filing 0000947871-21-000987
2021-09-02 S, Open-market sale Repare Therapeutics Inc.RPTX 2 lines 562,358, disposed Open Form 4 filing 0000947871-21-000978
2021-09-01 S, Open-market sale Repare Therapeutics Inc.RPTX 2 lines 440,653, disposed Open Form 4 filing 0000947871-21-000978
2021-08-31 S, Open-market sale Repare Therapeutics Inc.RPTX 2 lines 287,540, disposed Open Form 4 filing 0000947871-21-000978
2021-08-30 S, Open-market sale Repare Therapeutics Inc.RPTX 2 lines 227,162, disposed Open Form 4 filing 0000947871-21-000967
2021-08-27 S, Open-market sale Repare Therapeutics Inc.RPTX 2 lines 240,736, disposed Open Form 4 filing 0000947871-21-000967
2021-08-26 S, Open-market sale Repare Therapeutics Inc.RPTX 2 lines 147,849, disposed Open Form 4 filing 0000947871-21-000967
2021-08-25 S, Open-market sale Repare Therapeutics Inc.RPTX 2 lines 243,196, disposed Open Form 4 filing 0000947871-21-000960
2021-08-24 S, Open-market sale Repare Therapeutics Inc.RPTX 2 lines 137,609, disposed Open Form 4 filing 0000947871-21-000960
2021-08-23 S, Open-market sale Repare Therapeutics Inc.RPTX 2 lines 241,622, disposed Open Form 4 filing 0000947871-21-000960
2021-08-18 S, Open-market sale Repare Therapeutics Inc.RPTX 2 lines 99,591, disposed Open Form 4 filing 0000947871-21-000949
2021-08-18 S, Open-market sale Repare Therapeutics Inc.RPTX 2 lines 99,591, disposed Open Form 4 filing 0000947871-21-000959
2021-08-17 S, Open-market sale Repare Therapeutics Inc.RPTX 2 lines 593,620, disposed Open Form 4 filing 0000947871-21-000949
2021-08-17 S, Open-market sale Repare Therapeutics Inc.RPTX 2 lines 593,620, disposed Open Form 4 filing 0000947871-21-000959
2021-07-19 P, Open-market purchase Acutus Medical, Inc.AFIB 2 lines 14,999,992, acquired Open Form 4 filing 0000947871-21-000787
2021-07-16 P, Open-market purchase Imara Inc.IMRA 9,999,996, acquired Open Form 4 filing 0000947871-21-000798
2021-07-16 P, Open-market purchase Imara Inc.IMRA 9,999,996, acquired Open Form 4 filing 0000947871-21-000775
2021-03-30 P, Open-market purchase Ikena Oncology, Inc.IKNA 2 lines 6,774,400, acquired Open Form 4 filing 0000947871-21-000426
2021-03-30 P, Open-market purchase Ikena Oncology, Inc.IKNA 2 lines 6,774,400, acquired Open Form 4 filing 0000899243-21-014388

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 44
  • Open-market sale 42
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Bonita David P, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001572451

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.